K. M. Braaten, R. A. Betensky, L. de Leval, Y. Okada, F. H. Hochberg, D. N. Lous, et al., “BCL-6 Expression Predicts Improved Survival in Patients with Primary Central Nervous System Lymphoma,” Clinical Cancer Research, Vol. 9, No. 3, 2003, pp. 1063-1069.
-
TITLE:
Diffuse Large B-Cell Lymphoma of the Central Nervous System. Immunophenotype, Clinicopathological Features and Differential Diagnosis
AUTHORS:
Mónica Belinda Romero-Guadarrama, María Esther Gutiérrez Díaz-Ceballos, Fiacro Jiménez-Ponce, Samantha Thingen-Velarde
KEYWORDS:
Primary Lymphoma; Central Nervous System
JOURNAL NAME:
Open Journal of Pathology,
Vol.2 No.4,
October
31,
2012
ABSTRACT: Background: Diffuse large B-cell lymphomas of the central nervous system (DLBCL CNS) represent less than 1% of all lymphomas and between 2% and 3% of all cerebral tumors. They occur in adults of 60 years of age or more. The objective of this work is to describe the clinical-pathological characteristics, the immunophenotype and the differential diagnosis. Clinical Case: From the files of the surgical pathology unit we found four cases of primary diffuse large B cell lymphoma of the central nervous system in a 6-year period. Three corresponded to women over 47 years of age and the other to a 42-year-old man. The time of evolution was between 2 and 4 months. The symptoms were headache, blurred vision, hemiparesis, and seizures. Localization was in the pineal region, the frontal, parietal regions, and the right thalamus. Morphologically, large lymphoid cells with a diffuse growth pattern and necrosis were observed. Immunohistochemical markers, such as CD 20 and bcl2 were positive, one was positive to CD3. Expression of bcl6 and CD 10 was positive in one case, and MUM-1 was positive in three cases. All the cases were negative for Epstein-Barr virus. Conclusions: The diffuse large-B cell lymphoma of the central nervous system is rare. Its average age of presentation is at 60 years or older. The localization is in the pineal, frontal, parietal and thalamic regions. Three cases were originated by activated B lymphocyte (MUM-1 expression) and other from the Germinal Center (GC) (CD 10 expression). The clinical course was bad. The four patients died shortly after the diagnosis.
Related Articles:
Lack of MICA Expression Predicts a Worse Prognosis in Patients with Bladder Cancer
Mauricio Orozco-Levi, Alba Ramírez-Sarmiento, Michael Borchers, Cristiane Murta-Nascimento, Francesc Macià, Beatriz Casado, Maeba Polo, Andrea Caballero-Benitez, Fredy Diaz-Quijano, Antoni Gelabert
DOI:
10.4236/ojpathology.2013.31008
3,672 Downloads 6,185 Views Citations
Pub. Date:
January
29,
2013
Successful Treatment of Elderly Diffuse Large B-Cell Lymphoma with Central Nervous System Recurrence by Rituximab, Ranimusutine, Ifosfamide, Procarbazine, Dexamethasone, and Etoposide Therapy
Junya Miyahara, Naoki Takezako, Miyuki Wagatsuma, Kiyoe Midorikawa, Ichiro Fukuda, Satoshi Noto, Ikuo Saito, Kazuaki Yamada, Akiyoshi Miwa, Naohiro Sekiguchi
DOI:
10.4236/jct.2013.43A054
3,672 Downloads 6,208 Views Citations
Pub. Date:
March
7,
2013
